Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.
McHutchison JG, Bacon BR, Gordon SC, Lawitz E, Shiffman M, Afdhal NH, Jacobson IM, Muir A, Al-Adhami M, Morris ML, Lekstrom-Himes JA, Efler SM, Davis HL.
McHutchison JG, et al. Among authors: efler sm.
Hepatology. 2007 Nov;46(5):1341-9. doi: 10.1002/hep.21773.
Hepatology. 2007.
PMID: 17929306
Clinical Trial.